Galnet - Galician WordNet 3.0

logo sli

Explore Galnet

Galego | English

Version:
Search variants in 
ili-30-00838856-a CILI: i4604
WordNet Domains: quality
Top Ontology:
Basic Level Concept:
Epinonyms: [4] quality
[4] quality |1|
[3] ili-30-05190804-n (has_hyperonym) |1|
[2] ili-30-05199286-n (has_hyperonym) |1|
[1] ili-30-05199869-n (has_hyperonym) |1|
[0] ili-30-00838856-a (has_xpos_hyperonym) |1|
Polarity:
  positive negative
SentiWordNet: 0.5 0
ML-SentiCon: 0.625 0
Time:
  past present future atemporal
TempoWordNet: 0.002 0 0.998 0

Explore the terminological domain with [Termonet]
GL Variants
- eficaz [ɛfiˈkaθ] · [RILG] [DRAG]
a propaganda escrita é menos eficaz que os hábitos e os prexuízos ... dos lectores (Aldous Huxley)
o medicamento é eficaz para parar a tose
Gloss
marcado polas calidades que dan o poder de producir o efecto desexado
PT Variants
- eficaz [ifikˈaʃ]
Gloss
marcado por qualidades que o habilitam a produzir um efeito pretendido
ES Variants
- eficaz
EN Variants
- efficacious [ˌɛfə'keɪʃəs]
"written propaganda is less efficacious than the habits and prejudices...of the readers" -Aldous Huxley
the medicine is efficacious in stopping a cough
Gloss
marked by qualities giving the power to produce an intended effect
Lexical relations in WordNet via ILI (9) - Show / Hide graph:
Synonyms
(near_synonym)
00839225-a: works well as a means or remedy
Antonyms
(near_antonym)
00839411-a: lacking the power to produce a desired effect
Hyperonyms
(has_xpos_hyperonym)
05199869-n: capacity or power to produce a desired effect
Related
(has_derived)
00326324-r: in an effective manner
Related
(related_to)
05199869-n: capacity or power to produce a desired effect
Related
(see_also_wn15)
00834198-a: producing or capable of producing an intended result or having a striking effect
Glosses
(gloss)
00651991-v: be a distinctive feature, attribute, or trait; sometimes in a very positive sense
Glosses
(gloss)
01752884-v: cause to happen, occur or exist
Glosses
(rgloss)
00793212-n: a large clinical trial of a treatment or drug that in phase I and phase II has been shown to be efficacious with tolerable side effects; after successful conclusion of these clinical trials it will receive formal approval from the FDA